1. Cultivation optimization promotes ginsenoside and universal triterpenoid production by engineered yeast.
- Author
-
Qiu S, Gilani MDS, Müller C, Zarazua-Navarro RM, Liebal U, Eerlings R, and Blank LM
- Subjects
- Saccharomyces cerevisiae metabolism, Saccharomyces cerevisiae growth & development, Panax metabolism, Panax growth & development, Panax chemistry, Metabolic Engineering, Sapogenins, Ginsenosides biosynthesis, Ginsenosides metabolism, Triterpenes metabolism, Fermentation
- Abstract
Ginseng, a cornerstone of traditional herbal medicine in Asia, garnered significant attention for its therapeutic potential. Central to its pharmacological effects are ginsenosides, the primary active metabolites, many of which fall within the dammarane-type and share protopanaxadiol as a common precursor. Challenges in extracting protopanaxadiol and ginsenosides from ginseng arise due to their low concentrations in the roots. Emerging solutions involve leveraging microbial cell factories employing genetically engineered yeasts. Here, we optimized the fermentation conditions via the Design of Experiment, realizing 1.2 g/L protopanaxadiol in simple shake flask cultivations. Extrapolating the optimized setup to complex ginsenosides, like compound K, achieved 7.3-fold (0.22 g/L) titer improvements. Our adaptable fermentation conditions enable the production of high-value products, such as sustainable triterpenoids synthesis. Through synthetic biology, microbial engineering, and formulation studies, we pave the way for a scalable and sustainable production of bioactive compounds from ginseng., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF